Implementation of a national lenalidomide pregnancy prevention programme – Pathfinder Risk Management Platform by NHS England, NHS Scotland, NHS Wales and NHS Northern Ireland. – Webinar Sept 2022

Implementation of a national lenalidomide pregnancy prevention programme – Pathfinder Risk Management Platform by NHS England, NHS Scotland, NHS Wales and NHS Northern Ireland.

Webinar recording available to all PAID and FREE members now on the BOPA website!

Click here to view the video 

 

Latest News

By BOPA Committee on 16th May 2024

CRUK Consent Forms – NET and Prostate Cancer Update

The regimen specific consent forms for neuroendocrine and adrenal cancers have been reviewed, updated and added to the CRUK website. In addition, a new consent form for prostate has been…

Read article
By BOPA Research Committee on 15th May 2024

Survey on reach of CRUK SACT regimen-specific consent forms

The national regimen specific consent form project team would like you to complete a short survey to help us to  evaluate the uptake of  the regimen specific SACT consent forms…

Read article
By BOPA Research Committee on 15th May 2024

Survey: Investigating Physical Activity in Advanced Cancer Care

We are looking for healthcare professionals in the UK working with patients with advanced cancer to participate in a 10-minute survey as part of a study. The study titled: “Exploring Oncologists’ and…

Read article
By BOPA E&T Subcommittee on 13th May 2024

BOPA Collaboration Webinar – Highlights from COSA ASM 2023

Tuesday 25th June 2024 at 10:00 BST (19:00 ASET, 03:00 MDT)   The BOPA Education and Training Subcommittee would like to invite you to the next series of three-part collaboration…

Read article